Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
NeuroBo Pharmaceuticals, Inc. (NRBO)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
8 Feb 2018
Reno Seth
Chief Commercial Officer, Officer
Gemphire Therapeutics Inc.
(GEMP)
18,286
+3%
571.44
$175.00
$100,002.00
BUY
8 Feb 2018
Gullans Steven R. Ph.D.
Interim President & CEO, Director, Officer
Gemphire Therapeutics Inc.
(GEMP)
930,252
+0%
2,857.16
$175.00
$500,003.00
BUY
10 Mar 2017
SASSINE ANDY
Director
Gemphire Therapeutics Inc.
(GEMP)
136,264
+0%
844.76
$236.75
$199,996.94
BUY
10 Mar 2017
LICHTINGER PEDRO
Director
Gemphire Therapeutics Inc.
(GEMP)
59,833
+0%
422.36
$236.75
$99,993.73
BUY
10 Mar 2017
Hawryluk P. Kent
Director
Gemphire Therapeutics Inc.
(GEMP)
81,889
+1%
1,000
$236.75
$236,750.00
BUY
10 Mar 2017
Gullans Steven R. Ph.D.
Director
Gemphire Therapeutics Inc.
(GEMP)
858,823
+0%
2,111.92
$236.75
$499,997.06
BUY
10 Aug 2016
Sooch Mina
President & CEO, Director, Officer
Gemphire Therapeutics Inc.
(GEMP)
693,732
+0%
2,100
$250.00
$525,000.00
BUY
10 Aug 2016
Lowenschuss David
Chief Legal Off. & Secretary, Officer
Gemphire Therapeutics Inc.
(GEMP)
806,247
+0%
444.8
$250.00
$111,200.00
BUY
10 Aug 2016
MATHIESEN JEFFREY S
Chief Financial Officer, Officer
Gemphire Therapeutics Inc.
(GEMP)
7,927
+2%
160
$250.00
$40,000.00
BUY
10 Aug 2016
Hawryluk P. Kent
Director
Gemphire Therapeutics Inc.
(GEMP)
56,889
+1%
1,000
$250.00
$250,000.00
BUY
10 Aug 2016
LICHTINGER PEDRO
Director
Gemphire Therapeutics Inc.
(GEMP)
49,274
+0%
400
$250.00
$100,000.00
BUY
10 Aug 2016
KOUSKY KENNETH W
Director
Gemphire Therapeutics Inc.
(GEMP)
1,000
+4%
40
$250.00
$10,000.00
BUY
10 Aug 2016
Gullans Steven R. Ph.D.
Director
Gemphire Therapeutics Inc.
(GEMP)
806,025
+2%
20,000
$250.00
$5,000,000.00
BUY
10 Aug 2016
Reno Seth
Chief Commercial Officer, Officer
Gemphire Therapeutics Inc.
(GEMP)
4,000
+4%
160
$250.00
$40,000.00
BUY
10 Aug 2016
Bisgaier Charles PhD
Chair & Chief Scientific Off., Director, Officer, 10% Owner
Gemphire Therapeutics Inc.
(GEMP)
1,244,440
+0%
2,070
$250.00
$517,500.00
Home